Exhibit 1
CUSIP No.: 922107107
Joint Filing Statement
Pursuant to Rule 13d-1(k)(1)
The undersigned hereby consent and agree to the joint filing of Schedule 13G under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock, par value $0.001 per share of Vapotherm, Inc. beneficially owned by them, together with any or all amendments thereto, when and if appropriate. The parties hereto further consent and agree to file this Joint Filing Statement pursuant to Rule13d-1(k)(1)(iii) as an exhibit to Schedule 13G, thereby incorporating the same into such Schedule13G.
This Joint Filing Statement may be terminated by any of the undersigned upon written notice or such lesser period of notice as the undersigned may mutually agree.
| Dated: November 14, 2024 | ||
| Crow’s Nest Holdings LP | ||
| By: | Crow’s Nest Holdings GP LLC, its General partner | |
| By: | /s/ John A. Carrington | |
| John A. Carrington, Managing Member | ||
| Crow’s Nest Holdings Master Fund LP | ||
| By: | Crow’s Nest Holdings LP, its Investment Manager | |
| By: | Crow’s Nest Holdings GP LLC, the General Partner of the Investment Manager | |
| By: | /s/ John A. Carrington | |
| John A. Carrington, Managing Member | ||
| Crow’s Nest GP LLC | ||
| By: | /s/ John A. Carrington | |
| John A. Carrington, Managing Member | ||
| John A. Carrington | ||
| By: | /s/ John A. Carrington | |
| John A. Carrington, Individually | ||
